Ledger. Australian venture funding, tracked

Professor of Medicine, Harvard Medical School

Dr Jagmeet P. Singh

Coverage

Stories naming Dr Jagmeet P. Singh. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Unnamed stage $30m+

EBR Systems meets endpoints early in pivotal SOLVE-CRT trial: paves way for FDA approval application and commercialisation

Cardiac pacing company EBR Systems says its SOLVE-CRT trial hit its safety and efficacy goals early, keeping a 2024 US approval bid on course; the article also recalls its 2021 ASX listing.

Also Brandon BioCatalyst portfolio

Something wrong? Tell us